| Studying human neurological disorders using induced pluripotent stem cells: from 2D monolayer to 3D organoid and blood brain barrier models S Logan, T Arzua, SG Canfield, ER Seminary, SL Sison, AD Ebert, X Bai Comprehensive Physiology 9 (2), 565, 2019 | 118 | 2019 |
| Decreased sirtuin deacetylase activity in LRRK2 G2019S iPSC-derived dopaminergic neurons AJ Schwab, SL Sison, MR Meade, KA Broniowska, JA Corbett, AD Ebert Stem cell reports 9 (6), 1839-1852, 2017 | 93 | 2017 |
| Astrocyte-produced miR-146a as a mediator of motor neuron loss in spinal muscular atrophy SL Sison, TN Patitucci, ER Seminary, E Villalon, CL Lorson, AD Ebert Human molecular genetics 26 (17), 3409-3420, 2017 | 73 | 2017 |
| Using patient-derived induced pluripotent stem cells to identify Parkinson’s disease-relevant phenotypes SL Sison, SC Vermilyea, ME Emborg, AD Ebert Current neurology and neuroscience reports 18, 1-14, 2018 | 52 | 2018 |
| Modeling protein aggregation and the heat shock response in ALS iPSC-derived motor neurons ER Seminary, SL Sison, AD Ebert Frontiers in neuroscience 12, 86, 2018 | 49 | 2018 |
| Human cytomegalovirus disruption of calcium signaling in neural progenitor cells and organoids SL Sison, BS O’Brien, AJ Johnson, ER Seminary, SS Terhune, AD Ebert Journal of virology 93 (17), 10.1128/jvi. 00954-19, 2019 | 47 | 2019 |
| AAV9-mediated delivery of miR-23a reduces disease severity in Smn2B/−SMA model mice KA Kaifer, E Villalón, BS O'Brien, SL Sison, CE Smith, ME Simon, ... Human molecular genetics 28 (19), 3199-3210, 2019 | 32 | 2019 |
| BAR-SH3 sorting nexins are conserved interacting proteins of Nervous wreck that organize synapses and promote neurotransmission FP Ukken, JJ Bruckner, KL Weir, SJ Hope, SL Sison, RM Birschbach, ... Journal of cell science 129 (1), 166-177, 2016 | 28 | 2016 |
| SRCP1 conveys resistance to polyglutamine aggregation S Santarriaga, HN Haver, AJ Kanack, AS Fikejs, SL Sison, JM Egner, ... Molecular cell 71 (2), 216-228. e7, 2018 | 19 | 2018 |
| Decreased NAD+ in dopaminergic neurons SL Sison, AD Ebert Aging (Albany NY) 10 (4), 526, 2018 | 6 | 2018 |
| Nicotinamide mononucleotide treatment increases NAD+ levels in an iPSC Model of Parkinson’s Disease BK Fulleylove-Krause, SL Sison, AD Ebert bioRxiv, 2020.05. 06.080911, 2020 | 2 | 2020 |
| Nicotinamide mononucleotide treatment increases NAD+ levels in an iPSC Model of Parkinson’s Disease but does not impact sirtuin activity B Fulleylove-Krause, S Sison, A Ebert | | 2020 |
| 846: Functionality of neural cells in CMV-infected organoids treated with maribavir A Johnson, E Seminary, S Sison, A Ebert, S Terhune American Journal of Obstetrics & Gynecology 218 (1), S505, 2018 | | 2018 |
| and Allison D. Ebert AJ Schwab, SL Sison, MR Meade, KA Broniowska, JA Corbett | | |
